Otsuka ICU Medical, a joint venture tied to Japan's Otsuka Pharmaceutical Factory, has issued a voluntary recall for one lot of 0.9% sodium chloride injection used intravenously. The action follows a possible label mix-up, according to Fierce Pharma.
The recall covers only that single lot. Sodium chloride 0.9% injection is a commonly used IV fluid, and a labeling error could create risks related to product identification or administration. The source does not provide a lot number, distribution details, or any reports of patient harm.
Since this article relies on one source, there are no independent reports to confirm or contradict the company's description of the issue. The recall appears to be a precautionary measure tied to a manufacturing or packaging concern.